Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

Rapid manufacturing of angiogenic cellular collagen patches for ischemic cardiomyopathy.

Rapid manufacturing of angiogenic cellular collagen patches for ischemic cardiomyopathy. Stem cells translational medicine Pfrender, E., Kim, S., Farag, J. A., Yajima, S., Kawai, Y., Kawago, K., Syed, U., Ikeda, G., Ueyama, T., Takashima, H., Dalal, A., Zhu, Y., Ichimura, K., Liu, Y., Moeinzadeh, S., Koltsov, J., Wu, J. C., Woo, Y. J., Yang, P. C., Yang, Y. P., Shudo, Y. 2025; 14 (9)

Abstract

One in ten Americans carry a lifetime risk of ischemic heart failure, the most severe form of ischemic heart disease. Carrying a nearly 50% five-year mortality rate, no interventional therapy exists to treat the underlying cause, microvascular malperfusion. In efforts to combat microvascular malperfusion, our group has utilized synergistic application of endothelial progenitor cells (EPCs) and smooth muscle cells (SMCs) to induce angiogenesis in ischemic myocardium.Cells are then embedded into a rapidly manufacturable compressed collagen (CC) patch to provide a biosimilar scaffold ready for transplantation. The performance of the cellular compressed collagen patch was then tested on a rodent acute myocardial infarction model of ischemic heart failure.By post-transplantation Day 28, the cellular CC patch improved left ventricular ejection fraction when compared to an acellular CC patch and control (cellular: 49.1 ± 1.8%; acellular: 38.0 ± 2.6%; control: 39.2 ± 2.1%; ANOVA P?=?.0006). Cellular CC patch transplantation also induced mature angiogenesis as shown by arteriolar density (cellular: 1084 ± 98 aSMA+vWF+/mm2; acellular: 338 ± 57 aSMA+vWF+/mm2; control: 449 ± 39 aSMA+vWF+/mm2; ANOVA P = .0003) and vascular maturation index (cellular: 0.67 ± 0.04; acellular: 0.48 ± 0.02; and control: 0.46 ± 0.04, P?=?.001).In conclusion, transplantation of a rapidly manufacturable EPC-SMC-based compressed collagen patch effectively rescues myocardial function by enhancing neovascularization and attenuating post-infarction myocardial injury.

View details for DOI 10.1093/stcltm/szaf035

View details for PubMedID 40973918

View details for PubMedCentralID PMC12449208